Positive KEYNOTE-522 Overall Survival Results in TNBC | AJMC
5:55
ajmc.com
Positive KEYNOTE-522 Overall Survival Results in TNBC | AJMC
The first overall survival analysis of the KEYNOTE-522 trial showed positive outcomes with neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab monotherapy vs neoadjuvant chemotherapy alone in high-risk early-stage triple-negative breast cancer (TNBC).
Sep 16, 2024
Pembrolizumab Uses
Identifying Uses for Immunotherapy Across Sarcoma Populations and Subtypes | CancerNetwork
Identifying Uses for Immunotherapy Across Sarcoma Populations and Subtypes | CancerNetwork
cancernetwork.com
1 month ago
Keytruda (pembrolizumab) vedlejší účinky, interakce, použití a otisk drogy - Zdraví 2026
Keytruda (pembrolizumab) vedlejší účinky, interakce, použití a otisk drogy - Zdraví 2026
oldmedic.com
Aug 24, 2019
Primary Results from the Phase 3 Leap-002 Study: Lenvatinib plus Pembrolizumab versus Lenvatinib as First-Line Therapy for Advanced Hepatocellular Carcinoma | OncLive
Primary Results from the Phase 3 Leap-002 Study: Lenvatinib plus Pembrolizumab versus Lenvatinib as First-Line Therapy for Advanced Hepatocellular Carcinoma | OncLive
onclive.com
Sep 29, 2022
Top videos
Overall Survival with Pembrolizumab in Breast Cancer | NEJM
2:27
Overall Survival with Pembrolizumab in Breast Cancer | NEJM
YouTubeNEJM Group
3K viewsNov 28, 2024
Watch Peter Schmid, MD, PhD, FRCP, of Barts Cancer Insitute discuss updated KEYNOTE-522 data showing that pembrolizumab plus chemotherapy improves EFS in early-stage #TNBC. https://www.onclive.com/view/dr-schmid-on-pembrolizumab-plus-chemotherapy-in-high-risk-early-stage-tnbc | OncLive
1:55
Watch Peter Schmid, MD, PhD, FRCP, of Barts Cancer Insitute discuss updated KEYNOTE-522 data showing that pembrolizumab plus chemotherapy improves EFS in early-stage #TNBC. https://www.onclive.com/view/dr-schmid-on-pembrolizumab-plus-chemotherapy-in-high-risk-early-stage-tnbc | OncLive
FacebookOncLive
55 viewsDec 4, 2024
KEYNOTE-522: Event-Free Survival With Neoadjuvant and Adjuvant Pembrolizumab in TNBC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
6:31
KEYNOTE-522: Event-Free Survival With Neoadjuvant and Adjuvant Pembrolizumab in TNBC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
targetedonc.com
Dec 15, 2023
Pembrolizumab Side Effects
Pembrolizumab (Keytruda): How It Works, Side Effects & What Patients Should Know
14:04
Pembrolizumab (Keytruda): How It Works, Side Effects & What Patients Should Know
YouTubeDEMIRxCARE
54 views4 months ago
💊What is PEMBROLIZUMAB?. Mechanism of Action, Dosage and Side Effects of Pembrolizumab (KEYTRUDA)💊
13:24
💊What is PEMBROLIZUMAB?. Mechanism of Action, Dosage and Side Effects of Pembrolizumab (KEYTRUDA)💊
YouTubeMedicines/Diseases
1.6K viewsJun 4, 2020
Keytruda (pembrolizumab) Benefits & Side effects
1:19
Keytruda (pembrolizumab) Benefits & Side effects
YouTubeariflive
40 views11 months ago
Overall Survival with Pembrolizumab in Breast Cancer | NEJM
2:27
Overall Survival with Pembrolizumab in Breast Cancer …
3K viewsNov 28, 2024
YouTubeNEJM Group
Watch Peter Schmid, MD, PhD, FRCP, of Barts Cancer Insitute discuss updated KEYNOTE-522 data showing that pembrolizumab plus chemotherapy improves EFS in early-stage #TNBC. https://www.onclive.com/view/dr-schmid-on-pembrolizumab-plus-chemotherapy-in-high-risk-early-stage-tnbc | OncLive
1:55
Watch Peter Schmid, MD, PhD, FRCP, of Barts Cancer Insitute dis…
55 viewsDec 4, 2024
FacebookOncLive
KEYNOTE-522: Event-Free Survival With Neoadjuvant and Adjuvant Pembrolizumab in TNBC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
6:31
KEYNOTE-522: Event-Free Survival With Neoadjuvant and Adjuvant P…
Dec 15, 2023
targetedonc.com
🩷 Early-Stage Triple Negative Breast Cancer (TNBC) ✔️ Sa KEYNOTE-522, mas mataas ang pCR sa chemo pembrolizumab (~65%) kumpara sa chemo alone (~51%). ✔️ Mas bumaba ang risk ng recurrence at mas gumanda ang event-free survival. ✔️ Kung chemo lang ang kaya — effective pa rin ito. ✔️ Kung may residual disease, may dagdag na proteksyon ang capecitabine (CREATE-X trial). ✔️ Huwag kalimutan ang breast tissue marker bago chemo para mas accurate at safe ang breast-conserving surgery. 🩺 Hindi pare-pare
2:45
🩷 Early-Stage Triple Negative Breast Cancer (TNBC) ✔️ Sa KEYNOTE-…
2K views3 months ago
FacebookDr. Emmeline De Los Santos- Cancer Surgeon …
KEYNOTE-522: final OS findings of pembrolizumab and chemotherapy in TNBC
5:01
KEYNOTE-522: final OS findings of pembrolizumab and chemotherap…
3.1K viewsSep 16, 2024
YouTubeVJOncology
Dr. Rugo on the Results of the KEYNOTE-522 Trial in TNBC | OncLive
Dr. Rugo on the Results of the KEYNOTE-522 Trial in TNBC | Onc…
May 21, 2020
onclive.com
Dr Schmid on the Use of Perioperative Pembrolizumab in TNBC | OncLive
4:11
Dr Schmid on the Use of Perioperative Pembrolizumab in T…
Dec 8, 2023
onclive.com
KEYNOTE-522: Neoadjuvant and Adjuvant Pembrolizumab in TNB…
Jun 1, 2022
onclive.com
Dr Lang on Real-World Outcomes With the KEYNOTE-522 Regimen i…
Feb 11, 2025
onclive.com
9:47
Immunotherapy in Early Breast Cancer: Hope or Hype?
1.4K viewsJun 29, 2024
YouTubeCancer Treatment Updates
0:50
Julie Lang, MD, discusses real-world outcomes of the neoadjuva…
122 viewsFeb 12, 2025
FacebookOncLive
SABCS 2022 Post Hoc Analysis of Adjuvant RT in the Phase 3 KEYN…
Dec 21, 2022
vumedi.com
3:09
KEYNOTE-522: Neoadjuvant and adjuvant pembrolizumab for early …
2.2K viewsSep 22, 2021
YouTubeVJOncology
34:12
Keynote-522
911 viewsFeb 3, 2023
YouTubeDr. Mohammed Fathy
4:50
Triple Negative Breast Cancer Update: Immunotherapy in stage …
4.3K viewsSep 17, 2024
YouTubeEleonora Teplinsky, MD
9:02
Phase 3 KEYNOTE-522 results: pembro/chemo neoadjuvant, pem…
2.4K viewsSep 29, 2019
YouTubeVJOncology
3:58
Pembrolizumab shows improvement in overall survival for clear cell ren…
458 viewsJan 24, 2025
YouTubeecancer
KEYNOTE-522: pembrolizumabe em pacientes com câncer de mama tri…
Dec 9, 2021
oncologiabrasil.com.br
Dr. Costa on the Implications of the KEYNOTE-522 Trial in TNBC | Onc…
Feb 15, 2023
onclive.com
4:20
KEYNOTE-522: 5-year follow-up of pembrolizumab in triple-negative …
4.7K viewsOct 25, 2023
YouTubeVJOncology
4:54
KEYNOTE-522 updates: Pembrolizumab plus neoadjuvant …
734 viewsJan 7, 2020
YouTubeecancer
13:26
Newly diagnosed with Triple Negative Breast Cancer
1.3K views5 months ago
YouTubeLaura G
KEYNOTE-826: Pembrolizumab Plus Chemotherapy in Advanced Cervi…
Sep 19, 2021
ascopost.com
5:03
ESMO 2024 | KEYNOTE-522: Pembrolizumab (Immuntherapie) b…
3K viewsSep 20, 2024
YouTubeBrustkrebs Deutschland e.V.
20:27
Chemo for Triple Negative Breast Cancer is Finished!!
173 views2 weeks ago
YouTubeLaura G
1:41
Pembrolizumab Improves 5-Year Survival in Advanced NSCLC in K…
328 viewsJul 10, 2019
YouTubeTargeted Oncology
11:45
SABCS Snippets: KEYNOTE-522 Phase 3 Results
660 viewsMay 29, 2024
YouTubeSan Antonio Breast Cancer Symposium
14:06
Recap of chemo side effects from infusion #3 of Keynote 522 treatm…
335 views3 months ago
YouTubeLaura G
14:21
Halftime Recap Of Chemotherapy for Triple Negative Breast Cancer
1.2K views3 months ago
YouTubeLaura G
See more videos
Static thumbnail place holder